Aigenpulse
Aigenpulse is a data management and analytics platform focused on life sciences, particularly clinical trials and pharmaceutical research.
Profile
A data platform for managing and analyzing life sciences research data.
Aigenpulse is a data management and analytics platform focused on life sciences, particularly clinical trials and pharmaceutical research. Founded by Satnam Surae, who serves as CTO, the company targets the growing need for efficient handling of scientific data in drug development. Its platform integrates machine learning to accelerate clinical trials, with a technical architecture designed by contractors like Sylvain Duquenne.
The team includes specialists such as Shyama Saha, PhD, who brings expertise in NLP, LLM, and computer vision. While the company's website provides minimal operational details, its LinkedIn presence suggests a focus on high-performance computing and algorithm design for life sciences. Aigenpulse appears to cater primarily to large pharmaceutical companies, though specific customer names or revenue figures are not publicly disclosed. The platform's value proposition lies in its ability to manage and analyze complex scientific data, though the lack of recent funding announcements or headcount data raises questions about its current scale.
Who buys this
- Pharmaceutical companies conducting clinical trials
- Biotech firms with large-scale research data
- Academic medical centers involved in drug discovery
- Contract research organizations (CROs)
Strengths and what to watch
Strengths
- Technical team with deep expertise in ML and high-performance computing
- Focus on a high-value niche (clinical trials acceleration)
- CTO with prior entrepreneurial experience in data platforms
Watch for
- No recent funding announcements or growth metrics available
- Website provides minimal operational details beyond cookie policies
- Heavy reliance on contractor talent per LinkedIn profiles
Key Information
- Founded
- 2016
- Headquarters
- London, England, United Kingdom
Frequently Asked Questions
What is Aigenpulse?
Aigenpulse provides a data platform for life sciences research, specializing in clinical trials and pharmaceutical data management. Their system integrates machine learning to accelerate drug development processes, serving biotech firms, academic medical centers, and contract research organizations. The team includes experts in NLP and computer vision.
How does Aigenpulse help with clinical trials?
Aigenpulse's platform manages and analyzes clinical trial data using machine learning, aiming to accelerate research timelines. It handles complex scientific datasets for pharmaceutical companies and research organizations, though specific performance metrics aren't publicly disclosed. Their technical architecture is designed by specialists in high-performance computing.
Who uses Aigenpulse's platform?
Primary users include pharmaceutical companies conducting trials, biotech firms with large research datasets, academic medical centers, and contract research organizations. The platform caters to institutions needing advanced data management and analytics capabilities for drug discovery and development processes.
What makes Aigenpulse different from other life science data platforms?
Aigenpulse combines clinical trial data management with machine learning, backed by a team with NLP and computer vision expertise. Their focus on pharmaceutical research acceleration and high-performance computing architecture differentiates them, though detailed feature comparisons aren't available publicly.
Does Aigenpulse use AI for drug discovery?
Yes, Aigenpulse integrates machine learning into its life sciences platform to analyze research data and potentially accelerate drug discovery. Their team includes specialists in AI applications like natural language processing, though specific algorithms or success rates aren't detailed on their website.
How can I evaluate Aigenpulse for my research organization?
Potential users should contact Aigenpulse directly, as their website provides limited operational details. Consider their expertise in clinical trial data and ML capabilities against your requirements. Note that funding history and customer case studies aren't publicly available for benchmarking.
Sources
- be.linkedin.com — ML architecture for clinical trials products
- uk.linkedin.com — NLP and computer vision expertise on team
- uk.linkedin.com — CTO background and company focus area
- www.aigenpulse.com — Company website existence (though minimal content)